AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Septerna Inc. Common Stoc... (SEPN)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

5.88

0.33 (5.95%)

At close: Feb 20, 2025, 3:59 PM

5.79

-1.53%

After-hours: Feb 20, 2025, 04:56 PM EST

undefined% (undefined)

Bid	5.47
Market Cap	261.09M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-0.47
PE Ratio (ttm)	-12.51
Forward PE	n/a
Analyst	Buy

Ask	6.11
Volume	1,329,676
Avg. Volume (20D)	477,608
Open	5.48
Previous Close	5.55
Day's Range	5.25 - 6.22
52-Week Range	4.17 - 28.99
Beta	undefined

About SEPN

A detailed description of the company is not yet available....

[Show more]

Industry n/a

Sector n/a

IPO Date n/a

Employees 73

Stock Exchange NASDAQ

Ticker Symbol SEPN

Full Company Profile

Analyst Forecast

According to 4 analyst ratings, the average rating for SEPN stock is "Buy." The 12-month stock price forecast is $38, which is an increase of 546.26% from the latest price.

Buy 75.00%

Hold 25.00%

Sell 0.00%

Stock Forecasts

Why Price Moved

3 days ago

-46.99%

Septerna shares are trading lower after the compan... Unlock content with Pro Subscription

News

1 day ago · accessnewswire.com

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Septerna, Inc. (SEPN) And Encourages Investors to Reach Out

NEW YORK, NY / ACCESS Newswire / February 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Septerna, Inc. ("Septerna" or "the Company") (NASDA...

2 days ago · accessnewswire.com

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Septerna, Inc. (SEPN) And Encourages Stockholders to Reach Out

NEW YORK, NY / ACCESS Newswire / February 19, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Septerna, Inc. ("Septerna" or "the Company") (NASDA...

2 days ago · accessnewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Septerna, Inc. - SEPN

NEW YORK, NY / ACCESS Newswire / February 19, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Septerna, Inc ("Septerna" or the "Company") (NASDAQ:SEPN). Such investors are advis...

3 days ago · proactiveinvestors.com

Septerna halts Phase 1 hypoparathyroidism trial, shares plummet

Septerna (NASDAQ:SEPN) shares tumbled more than 60% after the clinical-stage biotechnology firm announced it is halting its Phase 1 clinical trial of SEP-786 targeting hypoparathyroidism. The company ...

3 days ago · accessnewswire.com

Septerna Stock Alert: Company Announces Discontinuation of Phase 1 Clinical Trial, Shares Plummet - Kehoe Law Firm, P.C. Investigating Securities Claims on Behalf of SEPN Investors

PHILADELPHIA, PA / ACCESS Newswire / February 18, 2025 / Kehoe Law Firm, P.C. is investigating securities claims on behalf of investors of Septerna, Inc. ("Septerna" or the "Company") (NASDAQ:SEPN).